TECRP2

Across TCGA pan-cancer cohorts, TECRP2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TECRP2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where TECRP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TECRP2 is over-expressed in tumor, although a few such as READ show the opposite, repressed pattern.

COAD, READ, and THCA are the cancer types where TECRP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TECRP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.777	<.001	8	view →
READ	All	III,IV	−0.090	.046	2	view →
THCA	Male	III,IV	+0.048	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

TECRP2–COAD

Open the COAD breakdown →